We use cookies for a better user experience. Read our Privacy Policy

I Agree

Craniomaxillofacial Implants Market

Craniomaxillofacial Implants Market (Location: Internal and External Fixators; Composition: Calcium Ceramics, Metals and Alloys, Polymers, and Biologic Materials; Nature: Non-resorbable and Resorbable Fixators; Type: Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

 
With the emergence of resorbable implants, craniomaxillofacial implants are undergoing rapid technological advancement in order to establish an effective treatment platform for facial reconstruction and augmentation. Factors such as growing geriatric population, increasing demand for customized craniomaxillofacial implants, and rising number of road accidents are driving the growth of the global craniomaxillofacial implants market. Furthermore, increasing number of national craniomaxillofacial surgery centers globally that is playing a crucial role in augmenting public awareness about craniomaxillofacial implants and surgery, is another key factor anticipated to support the growth of the craniomaxillofacial implants market. However high cost of the craniomaxillofacial surgery, and lack of appropriate health insurance schemes in developing nations is anticipated to pull back the growth of craniomaxillofacial implants market.
 
Based on location, the global craniomaxillofacial implants market has been segmented into internal and external fixators. The internal fixator segment accounted for the largest share of the craniomaxillofacial implants market in terms of revenue in 2013. Lesser infection rates, lower incidence of improper healing and stable nature of internal fixators are the major factors attributed to the leading position of the segment. The internal fixator segment is also expected to grow at the highest CAGR during the forecast period due to improvements in the metallurgical formulation of internal fixators, which have in turn increased their corrosion resistance.   
 
The composition segment in the craniomaxillofacial implants market has been categorized into calcium ceramics, metals and alloys, polymers, and biologic materials. Metals and alloys was witnessed as the largest segment in terms of revenue in 2013. The dominance of metals and alloys was majorly witnessed due to improved strength to weight ratio, and better biocompatibility and osseointegration property of metallic craniomaxillofacial implants. However, the biologic material segment is expected to foresee fastest growth rate during the forecast period from 2014 to 2022 due to flexible and resorbable nature of the material, which readily takes any anatomical shape as per the requirement. Furthermore, craniomaxillofacial implants made from biologic material are non-toxic in nature with no inflammatory response, hence accelerating the growth of the market segment during the forecast period. 
 
For the research study, the craniomaxillofacial implants market on the basis of implant nature has been segmented into non-resorbable and resorbable fixators. The non-resorbable fixator segment accounted for the largest share in 2013 due to wide commercial availability and compatibility with the facial tissues. On the other hand, resorbable fixator segment is estimated to witness fastest growth rate during the forecast period. The resorbable fixator gets reabsorbed in the tissue and hence, eliminates the need for repetitive surgical interventions, thereby boosting the growth of this fixator type. 
 
Based on various product types, the craniomaxillofacial implants market has been segmented into plate and screw fixator systems, bone graft substitutes, distraction systems, and temporomandibular joint (TMJ) replacement devices. Plate and screw fixator system held the largest share of the global craniomaxillofacial implants market in 2013. Plate and screw fixators system provide minimum damage to bones and tissues, hence is considered as the most reliable method for the internal fixation of facial and cranial bones. On the other hand, distraction systems are anticipated to expand at the highest CAGR during the forecast period due to increasing jaw deformities resulting from road accidents and genetic problems. The market for distraction systems would show swift growth as these devices result in superior jaw reconstruction which are unavailable with other standard techniques. 
 
Geographically, North America accounted for the largest share of the global craniomaxillofacial implants market in 2013. Factors attributed to the dominant position of North America in craniomaxillofacial implants market were high prevalence of facial injuries and with acceptance of technologically advanced craniomaxillofacial implants. According to the American Association for the Surgery of Trauma, craniomaxillofacial injuries account for over 150,000 deaths every year in the U.S. alone. However, Asia Pacific is anticipated to witness the highest growth during the forecast period. Fastest growth rate in this region is anticipated to emerge due to high prevalence of hereditary facial abnormalities, presence of large base of geriatric population, and improving healthcare infrastructure. According to the latest report published by the National Crime Records Bureau (NCRB), with over 130,000 deaths per year, India has currently has the worst road accident rate in Asia Pacific. Hence, rising rate of road accidents per year in Asian countries is also projected to increase the demand of craniomaxillofacial implants.
 
The global craniomaxillofacial implants market is fragmented due to the presence of numerous established as well as emerging players. The prominent companies operating in the craniomaxillofacial implants market includes DePuy Synthes, Stryker Corporation, Biomet, Inc., KLS Martin LP, OsteoMed, Anatomics Pty. Ltd., BIOPORE Surgical Implants, Matrix Surgical USA, Medical Vision Australia Holdings, Poriferous, LLC, General Implants GmbH, Osteotec Ltd., Rebstock Instruments GmbH, B. Braun Melsungen AG, Medartis AG, Medtronic, Inc. and others.
Craniomaxillofacial Implants Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Craniomaxillofacial Implants Market
2.2 Comparative Analysis: Global Craniomaxillofacial Implants Market Revenue, by Geography, 2013 and 2022 (Value %)
 
Chapter 3 Global Craniomaxillofacial Implants Market Overview
3.1 Introduction
3.2 Market Drivers
      3.2.1 Constant rise in incidence of facial fractures
      3.2.2 Emergence of new technological advancements and minimally invasive techniques in the field of trauma fixation
      3.2.3 Increased health care expenditure globally
3.3 Market Restraints
      3.3.1 High cost of craniomaxillofacial surgery
      3.3.2 Absence of health insurance schemes in developing countries
3.4 Market Opportunities      
      3.4.1 Shift from metallic to nonmetallic (bioresorbable) material for internal fixators
      3.4.2 Emerging economies to offer sustained growth opportunities
3.5 Porter’s Five Forces Analysis: Global Craniomaxillofacial Implants Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Regulatory Framework: Global Craniomaxillofacial Implants Market
3.7 Value Chain Analysis: Global Craniomaxillofacial Implants Market
3.8 Market Attractiveness Analysis: Global Craniomaxillofacial Implants Market, by Geography
3.9 Competitive Landscape
      3.9.1 Market Share by Key Players of the Global Craniomaxillofacial Implants Market, 2013 (%)
 
Chapter 4 Global Craniomaxillofacial Implants Market, by Location
4.1 Overview
      4.1.1 Global Craniomaxillofacial Implants Market Revenue, by Location, 2012 – 2022 (USD Million)
4.2 Internal Fixators
      4.2.1 Global Internal Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
4.3 External Fixators
      4.3.1 Global External Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 5 Global Craniomaxillofacial Implants Market, by Composition
5.1 Overview
      5.1.1 Global Craniomaxillofacial Implants Market Revenue, by Composition, 2012 – 2022 (USD Million)
      5.1.2 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Composition, 2013 and 2022 (Value %)
5.2 Calcium Ceramics
      5.2.1 Global Calcium Ceramics Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
5.3 Metals and Alloys
      5.3.1 Global Metals and Alloys Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
5.4 Polymers
      5.4.1 Global Polymers Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
5.5 Biologic Materials
      5.5.1 Global Biologic Materials Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 6 Global Craniomaxillofacial Implants Market, by Nature
6.1 Overview
      6.1.1 Global Craniomaxillofacial Implants Market Revenue, by Nature, 2012 – 2022 (USD Million)
6.2 Non-resorbable Fixators
      6.2.1 Global Non-resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
6.3 Resorbable Fixators
      6.3.1 Global Resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 7 Global Craniomaxillofacial Implants Market, by Product
7.1 Overview
      7.1.1 Global Craniomaxillofacial Implants Market Revenue, by Product, 2012 – 2022 (USD Million)
      7.1.2 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Type, 2013 and 2022 (Value %)
7.2 Plate and Screw Fixator Systems
      7.2.1 Global Plate and Screw Fixator Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
7.3 Bone Graft Substitutes
      7.3.1 Global Bone Graft Substitutes in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
7.4 Distraction Systems
      7.4.1 Global Distraction Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
7.5 Temporomandibular Joint (TMJ) Replacement Devices
      7.5.1 Global TMJ Replacement Devices in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 8 Global Craniomaxillofacial Implants Market, by Geography
8.1 Overview
      8.1.1 Global Craniomaxillofacial Implants Market Revenue, by Geography, 2012 – 2022 (USD Million)
8.2 North America
      8.2.1 North America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
      8.2.2 U.S. Craniomaxillofacial Implants Market Revenue, 2012 - 2022 (USD Million)
      8.2.3 Canada Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.3 Europe
      8.3.1 Europe Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
      8.3.2 U.K. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.3.3 Germany Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.3.4 France Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.3.5 Rest of Europe Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.4 Asia Pacific
      8.4.1 Asia Pacific Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
      8.4.2 Japan Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.4.3 China Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.4.4 Rest of Asia Pacific Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.5 Latin America
      8.5.1 Latin America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
      8.5.2 Brazil Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.5.3 Rest of Latin America Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.6 MENA
      8.6.1 MENA Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
      8.6.2 UAE Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
      8.6.3 Rest of MENA Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.7 Rest of the World (RoW)
      8.7.1 Rest of the World Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
 
Chapter 9 Recommendations
 
Chapter 10 Company Profiles
10.1 Anatomics Pty Ltd
      10.1.1 Company Overview
      10.1.2 Financial Overview
      10.1.3 Product Portfolio
      10.1.4 Business Strategies
      10.1.5 Recent Developments
10.2 B. Braun Melsungen AG
      10.2.1 Company Overview
      10.2.2 Financial Overview
      10.2.3 Product Portfolio
      10.2.4 Business Strategy
      10.2.5 Recent Developments
10.3 Biomet, Inc.
      10.3.1 Company Overview
      10.3.2 Financial Overview
      10.3.3 Product Portfolio
      10.3.4 Business Strategies
      10.3.5 Recent Developments
10.4 BIOPORE Surgicals
      10.4.1 Company Overview
      10.4.2 Financial Overview
      10.4.3 Product Portfolio
      10.4.4 Business Strategies
10.5 Boston Medical Products, Inc.
      10.5.1 Company Overview
      10.5.2 Financial Overview
      10.5.3 Product Portfolio
      10.5.4 Business Strategies
      10.5.5 Recent Developments
10.6 Calavera Surgical Design, Inc.
      10.6.1 Company Overview
      10.6.2 Financial Overview
      10.6.3 Product Portfolio
      10.6.4 Business Strategies
      10.6.5 Recent Developments
10.7 Cavendish Implants Ltd.
      10.7.1 Company Overview
      10.7.2 Financial Overview
      10.7.3 Product Portfolio
      10.7.4 Business Strategies
      10.7.5 Recent Developments
10.8 CONMED Corporation
      10.8.1 Company Overview
      10.8.2 Financial Overview
      10.8.3 Product Portfolio
      10.8.4 Business Strategies
      10.8.5 Recent Developments
10.9 DePuySynthes, Inc. (a J & J Company)
      10.9.1 Company Overview
      10.9.2 Financial Overview
      10.9.3 Product Portfolio
      10.9.4 Business Strategies
      10.9.5 Recent Developments
10.10 ELLA-CS, s.r.o.
      10.10.1 Company Overview
      10.10.2 Financial Overview
      10.10.3 Product Portfolio
      10.10.4 Business Strategies
      10.10.5 Recent Developments
10.11 General Implants GmbH
      10.11.1 Company Overview
      10.11.2 Financial Overview
      10.11.3 Product Portfolio
      10.11.4 Business Strategies
      10.11.5 Recent Developments
10.12 GPC Medical Limited
      10.12.1 Company Overview
      10.12.2 Financial Overview
      10.12.3 Product Portfolio
      10.12.4 Business Strategies
      10.12.5 Recent Developments
10.13 Integra LifeSciences Corporation
      10.13.1 Company Overview
      10.13.2 Financial Overview
      10.13.3 Product Portfolio
      10.13.4 Business Strategies
      10.13.5 Recent Developments
10.14 KLS Martin LP
      10.14.1 Company Overview
      10.14.2 Financial Overview
      10.14.3 Product Portfolio
      10.14.4 Business Strategies
      10.14.5 Recent Developments
10.15 Matrix Surgical USA
      10.15.1 Company Overview
      10.15.2 Financial Overview
      10.15.3 Product Portfolio
      10.15.4 Business Strategies
      10.15.5 Recent Developments
10.16 Medartis AG
      10.16.1 Company Overview
      10.16.2 Financial Overview
      10.16.3 Product Portfolio
      10.16.4 Business Strategies
      10.16.5 Recent Developments
10.17 Medical Vision Australia Holdings
      10.17.1 Company Overview
      10.17.2 Financial Overview
      10.17.3 Product Portfolio
      10.17.4 Business Strategies
      10.17.5 Recent Developments
10.18 Medtronic, Inc.
      10.18.1 Company Overview
      10.18.2 Financial Overview
      10.18.3 Product Portfolio
      10.18.4 Business Strategies
      10.18.5 Recent Developments
10.19 Narang Medical Limited
      10.19.1 Company Overview
      10.19.2 Financial Overview
      10.19.3 Product Portfolio
      10.19.4 Business Strategies
      10.19.5 Recent Developments
10.20 Naton Medical Group
      10.20.1 Company Overview
      10.20.2 Financial Overview
      10.20.3 Product Portfolio
      10.20.4 Business Strategies
      10.20.5 Recent Developments
10.21 Ningbo Cibei Medical Treatment Appliance Co. Ltd.
      10.21.1 Company Overview
      10.21.2 Financial Overview
      10.21.3 Product Portfolio
      10.21.4 Business Strategies
10.22 NRV OrthoTech Pvt Ltd
      10.22.1 Company Overview
      10.22.2 Financial Overview
      10.22.3 Product Portfolio
      10.22.4 Business Strategies
      10.22.5 Recent Developments
10.23 O & M Medical GmbH
      10.23.1 Company Overview
      10.23.2 Financial Overview
      10.23.3 Product Portfolio
      10.23.4 Business Strategies
      10.23.5 Recent Developments
10.24 Ortho Max Manufacturing Company Pvt. Ltd.
      10.24.1 Company Overview
      10.24.2 Financial Overview
      10.24.3 Product Portfolio
      10.24.4 Business Strategies
      10.24.5 Recent Developments
10.25 OsteoMed
      10.25.1 Company Overview
      10.25.2 Financial Overview
      10.25.3 Product Portfolio
      10.25.4 Business Strategies
      10.25.5 Recent Developments
10.26 Osteotec Ltd
      10.26.1 Company Overview
      10.26.2 Financial Overview
      10.26.3 Product Portfolio
      10.26.4 Business Strategies
      10.26.5 Recent Developments
10.27 Poriferous, LLC
      10.27.1 Company Overview
      10.27.2 Financial Overview
      10.27.3 Product Portfolio
      10.27.4 Business Strategies
      10.27.5 Recent Developments
10.28 Rebstock Instruments GmbH
      10.28.1 Company Overview
      10.28.2 Financial Overview
      10.28.3 Product Portfolio
      10.28.4 Business Strategies
      10.28.5 Recent Developments
10.29 S. H. Pitkar Orthotools Pvt. Ltd.
      10.29.1 Company Overview
      10.29.2 Financial Overview
      10.29.3 Product Portfolio
      10.29.4 Business Strategies
      10.29.5 Recent Developments
10.30 Shenzhen World Surgery Medical Device Technology Co., Ltd
      10.30.1 Company Overview
      10.30.2 Financial Overview
      10.30.3 Product Portfolio
      10.30.4 Business Strategies
      10.30.5 Recent Developments
10.31 Stryker Corporation
      10.31.1 Company Overview
      10.31.2 Financial Overview
      10.31.3 Product Portfolio
      10.31.4 Business Strategies
      10.31.5 Recent Developments
10.32 Zimmer Holdings, Inc.
      10.32.1 Company Overview
      10.32.2 Financial Overview
      10.32.3 Product Portfolio
      10.32.4 Business Strategies
      10.32.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Craniomaxillofacial Implants Market
TABLE 2 Global Craniomaxillofacial Implants Market Revenue, by Location, 2012 – 2022 (USD Million)
TABLE 3 Global Craniomaxillofacial Implants Market Revenue, by Composition, 2012 – 2022 (USD Million)
TABLE 4 Global Craniomaxillofacial Implants Market Revenue, by Nature, 2012 – 2022 (USD Million)
TABLE 5 Global Craniomaxillofacial Implants Market Revenue, by Product, 2012 – 2022 (USD Million)
TABLE 6 Global Craniomaxillofacial Implants Market Revenue, by Geography, 2012 – 2022 (USD Million)
TABLE 7 North America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 8 Europe Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 9 Asia Pacific Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 10 Latin America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 11 MENA Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
List of Figures
 
FIG. 1 Craniomaxillofacial Implants: Market Segmentation
FIG. 2 Global Craniomaxillofacial Implants Market, by Location and Composition, 2013 (USD Million)
FIG. 3 Global Craniomaxillofacial Implants Market, by Nature and Type, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Craniomaxillofacial Implants Market Revenue, by Geography, 2013 and 2022 (Value %)
FIG. 5 Porter’s Five Forces Analysis: Global Craniomaxillofacial Implants Market
FIG. 6 Value Chain Analysis: Global Craniomaxillofacial Implants Market
FIG. 7 Market Attractiveness Analysis: Global Craniomaxillofacial Implants Market, by Geography (2013)
FIG. 8 Craniomaxillofacial Implants Market Share by Key Players, 2013 (%)
FIG. 9 Global Internal Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 10 Global External Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 11 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Composition, 2013 and 2022 (Value %)
FIG. 12 Global Calcium Ceramics Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 13 Global Metals and Alloys Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 14 Global Polymers Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 15 Global Biologic Materials Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 16 Global Non-resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 17 Global Resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 18 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Type, 2013 and 2022 (Value %)
FIG. 19 Global Plate and Screw Fixator Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 20 Global Bone Graft Substitutes in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 21 Global Distraction Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 22 Global TMJ Replacement Devices in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 23 U.S. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 24 Canada Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 25 U.K. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 26 Germany Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 27 France Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 28 Rest of Europe Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 29 Japan Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 30 China Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 31 Rest of Asia Pacific Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 32 Brazil Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 33 Rest of Latin America Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 34 UAE Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 35 Rest of MENA Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 36 Rest of the World Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
FIG. 37 B. Braun Melsungen AG: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 38 CONMED: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 39 Johnson and Johnson Annual Revenue (USD Million) of Medical Devices Segment, 2012 – 2014
FIG. 40 Integra LifeSciences Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 41 Medtronic, Inc., Annual Revenue: 2011 – 2013 (USD Million)
FIG. 42 Stryker Corporation: Annual Revenue: 2011 – 2013 (USD Million)
FIG. 43 Zimmer Holdings, Inc. Annual Revenue: 2011 – 2013 (USD Million)
Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

359

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved